NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors

NCT04270461 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped Study is withdrawn because of administrative reasons

Conditions

Hepatocellular Carcinoma
Glioblastoma
Medulloblastoma
Colon Cancer

Interventions

BIOLOGICAL: NKG2D-based CAR T-cells

Sponsor

Jiujiang University Affiliated Hospital

Collaborators

[object Object]